Published in Am J Respir Crit Care Med on September 15, 2013
Virtual Exercise Program in Interstitial Lung Disease (ILD) Patients | NCT04946708
Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. Am J Respir Crit Care Med (2014) 2.77
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J (2015) 1.65
Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One (2014) 1.55
Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet (2015) 1.46
Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis. PLoS One (2015) 1.44
Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease. BMC Pulm Med (2015) 1.40
Diffuse Lung Disease in Biopsied Children 2 to 18 Years of Age. Application of the chILD Classification Scheme. Ann Am Thorac Soc (2015) 1.40
Normal Lung Quantification in Usual Interstitial Pneumonia Pattern: The Impact of Threshold-based Volumetric CT Analysis for the Staging of Idiopathic Pulmonary Fibrosis. PLoS One (2016) 1.39
Prognostic factors for myositis-associated interstitial lung disease. PLoS One (2014) 1.34
Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF). BMC Pulm Med (2014) 0.98
Quantitative stratification of diffuse parenchymal lung diseases. PLoS One (2014) 0.97
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer. Cancer Immunol Res (2016) 0.97
Pleuroparenchymal Fibroelastosis: Its Clinical Characteristics. Curr Respir Med Rev (2013) 0.95
PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course. Clin Cancer Res (2016) 0.94
Lung disease in rheumatoid arthritis. Rheum Dis Clin North Am (2015) 0.94
Update on therapeutic management of idiopathic pulmonary fibrosis. Ther Clin Risk Manag (2015) 0.91
Pleuroparenchymal fibroelastosis: role of high-resolution computed tomography (HRCT) and CT-guided transthoracic core lung biopsy. Insights Imaging (2015) 0.86
Drug-Related Pneumonitis During Mammalian Target of Rapamycin Inhibitor Therapy: Radiographic Pattern-Based Approach in Waldenström Macroglobulinemia as a Paradigm. Oncologist (2015) 0.86
Histological evolution of pleuroparenchymal fibroelastosis. Histopathology (2014) 0.85
Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease. BMC Med (2015) 0.84
Idiopathic pleuroparenchymal fibroelastosis presenting in recurrent pneumothorax: a case report. Tuberc Respir Dis (Seoul) (2014) 0.84
Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways. Physiol Rev (2016) 0.84
The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE). PLoS One (2014) 0.84
Interstitial lung disease in connective tissue disease--mechanisms and management. Nat Rev Rheumatol (2014) 0.83
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias. PLoS One (2015) 0.83
Idiopathic pleuroparenchymatous fibroelastosis: A case report and brief review of the literature. Respir Med Case Rep (2014) 0.83
IPF clinical trial design and endpoints. Curr Opin Pulm Med (2014) 0.83
Diagnosis and management of interstitial lung disease. Transl Respir Med (2014) 0.83
Preventive effects of vitamin D treatment on bleomycin-induced pulmonary fibrosis. Sci Rep (2015) 0.82
A Case of Organizing Pneumonia (OP) Associated with Pembrolizumab. Drug Target Insights (2016) 0.82
Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia. Respir Res (2014) 0.82
Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort study. Medicine (Baltimore) (2014) 0.82
Inflammatory lung disease in Rett syndrome. Mediators Inflamm (2014) 0.82
Clinicopathological findings of focal organizing pneumonia: a retrospective study of 37 cases. Int J Clin Exp Pathol (2015) 0.82
Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol (2016) 0.81
Diagnosis of pulmonary alveolar microlithiasis. Radiol Bras (2015) 0.81
Clinical characteristics of idiopathic pulmonary fibrosis patients with gender, age, and physiology staging at Okinawa Chubu Hospital. J Thorac Dis (2015) 0.81
Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non-small-cell lung cancer. Cancer Sci (2014) 0.81
MMP-7 and fcDNA serum levels in early NSCLC and idiopathic interstitial pneumonia: preliminary study. Int J Mol Sci (2013) 0.81
Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis. Clin Rheumatol (2016) 0.81
Laying the ground for research of interstitial lung disease in our country: ILD India registry. Lung India (2014) 0.80
Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features. J Bras Pneumol (2015) 0.80
Interstitial lung disease: raising the index of suspicion in primary care. NPJ Prim Care Respir Med (2014) 0.80
Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J (2016) 0.80
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling. Respir Med (2016) 0.80
Clinical and radiological features of idiopathic interstitial pneumonias (IIPs): a pictorial review. Insights Imaging (2014) 0.79
Antisynthetase syndrome: An under-recognized cause of interstitial lung disease. Lung India (2016) 0.79
Diagnosis of idiopathic pulmonary fibrosis: Current issues. Intractable Rare Dis Res (2015) 0.79
Double-blind controlled trial of lecithinized superoxide dismutase in patients with idiopathic interstitial pneumonia - short term evaluation of safety and tolerability. BMC Pulm Med (2014) 0.79
Myriad Functions of Stanniocalcin-1 (STC1) Cover Multiple Therapeutic Targets in the Complicated Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). Clin Med Insights Circ Respir Pulm Med (2015) 0.79
Increased ectodomain shedding of cell adhesion molecule 1 as a cause of type II alveolar epithelial cell apoptosis in patients with idiopathic interstitial pneumonia. Respir Res (2015) 0.79
Thin-Section CT Characteristics and Longitudinal CT Follow-up of Chemotherapy Induced Interstitial Pneumonitis: A Retrospective Cohort Study. Medicine (Baltimore) (2016) 0.79
Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy in patients with neuroendocrine tumors: a radiographic pattern-based approach. Eur J Cancer (2016) 0.79
Transient Asymptomatic Pulmonary Opacities Occurring during Osimertinib Treatment. J Thorac Oncol (2016) 0.78
Acute Fibrinous and Organizing Pneumonia Associated With Allogenic Hematopoietic Stem Cell Transplant Successfully Treated With Corticosteroids: A Two-Patient Case Series. J Investig Med High Impact Case Rep (2016) 0.78
Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol (2017) 0.78
Chronic hypersensitivity pneumonitis: identification of key prognostic determinants using automated CT analysis. BMC Pulm Med (2017) 0.78
Clinical and Radiological Profile of Acute Fibrinous and Organizing Pneumonia: A Retrospective Study. Chin Med J (Engl) (2015) 0.78
Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres. BMC Pulm Med (2016) 0.78
Pathology of Idiopathic Interstitial Pneumonias. Clin Med Insights Circ Respir Pulm Med (2016) 0.78
Smoking-related interstitial lung disease. Dtsch Arztebl Int (2015) 0.78
Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study. PLoS One (2015) 0.78
Idiopathic pleuroparenchymal fibroelastosis is characterized by an elevated serum level of surfactant protein-D, but Not Krebs von den Lungen-6. Lung (2014) 0.78
Interstitial lung diseases in the hospitalized patient. BMC Med (2015) 0.78
Pulmonary fibrosis and emphysema: Is the emphysema type associated with the pattern of fibrosis? World J Radiol (2015) 0.78
Severe drug-induced interstitial lung disease successfully treated with corticosteroid plus recombinant human soluble thrombomodulin. BMJ Case Rep (2014) 0.78
Activation of oncogenic pathways in idiopathic pulmonary fibrosis. Transl Oncol (2014) 0.78
Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease. Clin Med Insights Circ Respir Pulm Med (2016) 0.78
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF. PLoS One (2016) 0.78
Astaxanthin prevents pulmonary fibrosis by promoting myofibroblast apoptosis dependent on Drp1-mediated mitochondrial fission. J Cell Mol Med (2015) 0.78
A retrospective study of prognostic factors in patients with interstitial pneumonia receiving long-term oxygen therapy. Lung (2014) 0.78
Tomography patterns of lung disease in systemic sclerosis. Radiol Bras (2016) 0.78
Idiopathic fibrotic lung disease at a university hospital setting: management and prognostic factors. Eur Clin Respir J (2015) 0.78
Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients. Diagn Interv Radiol (2016) 0.78
Clinical Course and Changes in High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without Honeycombing. PLoS One (2016) 0.78
Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease. Cell (2017) 0.78
Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias. Lung (2016) 0.77
Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS One (2014) 0.77
Pleuroparenchymal fibroelastosis associated with aluminosilicate dust: a case report. Int J Clin Exp Pathol (2015) 0.77
Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes. BMC Pulm Med (2016) 0.77
Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. BMC Pulm Med (2016) 0.77
Prognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease. J Cardiovasc Magn Reson (2015) 0.77
Sleep disordered breathing in interstitial lung disease: A review. World J Clin Cases (2014) 0.77
Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis. PLoS One (2016) 0.77
Diagnostic disparity of previous and revised American Thoracic Society guidelines for idiopathic pulmonary fibrosis. Can Respir J (2015) 0.76
Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status. J Thorac Dis (2016) 0.76
Airway-centered interstitial fibrosis: etiology, clinical findings and prognosis. Respir Res (2015) 0.76
Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis. Respir Res (2016) 0.76
State of the art in the diagnosis and management of interstitial lung disease. Clujul Med (2015) 0.76
Complex genetics of pulmonary diseases: lessons from genome-wide association studies and next-generation sequencing. Transl Res (2015) 0.76
Acute exacerbation of airspace enlargement with fibrosis. Respir Med Case Rep (2014) 0.75
Clinical impact of high-attenuation and cystic areas on computed tomography in fibrotic idiopathic interstitial pneumonias. BMC Pulm Med (2015) 0.75
Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experience. Ann Thorac Med (2015) 0.75
Is bronchoalveolar lavage a game changer in the diagnosis of interstitial lung disease? Lung India (2016) 0.75
The impact of different methods of DNA extraction on microbial community measures of BALF samples based on metagenomic data. Am J Transl Res (2016) 0.75
Idiopathic pleuroparenchymal fibroelastosis - A rare idiopathic interstitial pneumonia. Respir Med Case Rep (2015) 0.75
Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil. J Thorac Dis (2014) 0.75
Are interstitial lung abnormalities associated with COPD? A nested case-control study. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Pathological and radiological correlation in an autopsy case of combined pulmonary fibrosis and emphysema. Int J Chron Obstruct Pulmon Dis (2015) 0.75
HRCT in smoking-related interstitial lung diseases: a kaleidoscopic overlap of patterns. J Bras Pneumol (2016) 0.75
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell (2012) 11.69
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med (2014) 10.62
Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity (2009) 9.01
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature (2004) 8.35
Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67
Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res (2005) 7.66
High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2005) 7.20
Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology (2012) 6.92
Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med (2011) 6.74
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet (2005) 6.70
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med (2012) 6.51
A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med (2011) 6.40
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med (2015) 6.03
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med (2004) 6.02
Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A (2007) 5.95
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet (2011) 5.94
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol (2005) 5.88
Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation (2010) 5.87
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol (2015) 5.83
Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med (2008) 5.82
The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol (2007) 5.79
Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med (2004) 5.78
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med (2012) 5.37
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med (2012) 5.33
The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst (2012) 5.27
Idiopathic pulmonary fibrosis. Lancet (2011) 5.25
The 2004 World Health Organization classification of lung tumors. Semin Roentgenol (2005) 5.23
Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients. Am J Respir Crit Care Med (2012) 5.21